Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. gained 1.750% today.
The stock is one of the favorites of our community with 51 Buy predictions and 1 Sell predictions.
With a target price of 77 € there is a slightly positive potential of 18.03% for Ionis Pharmaceuticals Inc. compared to the current price of 65.24 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 1.750% | -1.110% | -0.804% | 169.073% | -5.650% | 87.980% | 80.264% |
| Ligand Pharmaceuticals | 1.140% | -2.235% | -4.372% | 90.217% | 5.422% | 153.623% | 34.564% |
| United Therapeutics | -0.100% | -0.429% | 3.615% | 96.730% | 14.042% | 134.957% | 184.971% |
| Novocure Ltd | -0.460% | -1.181% | -17.043% | -37.089% | -20.300% | -84.943% | -91.850% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat